PEPG · PepGen Inc.
$2.99
+0.01 (+0.34%)
At close · Aug 14
Market Cap
$207.09M
Shares
69.26M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.99
Open$2.95
Day$2.85–3.00
52W close$1.16–7.17
Avg vol 30d1.3M
Short int4.1M · 5.9% float · 6.1d
Short vol50%
Last earningsMar 30, 2026
DataMay 2022–Aug 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Mar 20, 2027
Est · unconfirmed
· in 31 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−21%
below
Price vs 50-day avg
+50%
above
RSI (14)
74
overbought
MACD trend
Positive
52-week position
30%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+33%
trailing
6-month return
−53%
trailing
YTD return
−54%
this year
Relative strength
−67%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow
Distributing
-24% holders QoQ · +7 funds added
Insider flow
Distributing
Net -$1.7K over 90 days · 100% sells
Short interest
Falling
5.93% of float · ▼ -9.4% MoM · 6.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
72 holders — mid 3-yr range
Squeeze score
66
elevated · 0–100
Fundamentals
EPS growth
+26%
Y/Y
Free cash flow
$-81.9M
Balance sheet
$60.5M
net cash
Quant / Vol
risk profile
Volatility
170%
annualized · 1-yr
Max drawdown
−81%
past year
ATR
7.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−21%
Bearish
Price vs 50-day avg
+50%
Bullish
RSI (14)
74
Bearish
MACD trend
Positive
Bullish
52-week position
30%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow
Distributing
-24% holders QoQ · +7 funds added
Insider flow
Distributing
Net -$1.7K over 90 days · 100% sells
Short interest
Falling
5.93% of float · ▼ -9.4% MoM · 6.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
72 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $3 · 30%
Range high $7
vs 200-day avg -21%
vs 50-day avg +50%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PEPG
this stock
PepGen Inc.
|
$207.09M | -54.1% | — | — | 5.9% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PEPG | +4.9% | +32.9% | -52.8% | +69.9% | -54.1% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +4.5% | +28.4% | -66.6% | +66.0% | -67.9% |
Key facts
CIK
1835597
CUSIP
713317105
13F (30d)
74 filings
73 filers
Visit website
Investor relations